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Background: Patient registries represent a well-established methodology for prospective data collection with a
wide array of applications for clinical research and health care administration. An examination and synthesis of regis-
try stakeholder perspectives has not been previously reported in the literature.
Methods: To inform the development of future neurological registries we examined stakeholder perspectives about
such registries through a literature review followed by 3 focus groups comprised of a total of 15 neurological
patients and 12 caregivers.
Results: (1) Literature review: We identified 6,435 abstracts after duplicates were removed. Of these, 410 articles
underwent full text review with 24 deemed relevant to perspectives about neurological and non-neurological regis-
tries and were included in the final synthesis. From a patient perspective the literature supports altruism, responsible
use of data and advancement of research, among others, as motivating factors for participating in a patient registry.
Barriers to participation included concerns about privacy and participant burden (i.e. extra clinic visits and associated
costs). (2) Focus groups: The focus groups identified factors that would encourage participation such as: having a
clear purpose; low participant burden; and being well-managed among others.
Conclusions: We report the first examination and synthesis of stakeholder perspectives on registries broadly with a
specific focus on neurological patient registries. The findings of the broad literature review were congruent with the
neurological patient and caregiver focus groups. We report common themes across the literature and the focus
groups performed. Stakeholder perspectives need to be considered when designing and operating patient
registries. Emphasizing factors that promote participation and mitigating barriers may enhance patient recruitment.
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Patient registries represent a well established method-
ology for prospective data collection with a wide array
of applications for clinical research and health care ad-
ministration [1]. In contrast to randomized controlled
clinical trials, patient registry data is often highly
generalizable to the source patient population and pro-
vides a complimentary mechanism to derive evidence
for clinical decision-making and management [2].
Some neurological conditions are sufficiently uncom-
mon or rare that single centre observational studies* Correspondence: korngut@gmail.com
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reproduction in any medium, provided the orand randomized controlled clinical trials are unfeasible
and thus are good candidates for studies through pa-
tient registries. Data sources for patient registries
range from clinic-based through administrative data
collection and often there is capture of patient demo-
graphic and/or medical data. As part of the Public
Health Agency of Canada’s National Population Health
Study of Neurological Conditions, we undertook the
development of Neurological Registry Best Practice
Guidelines for Canadian registries [3]. A key aspect of
successful guideline development is the incorporation
of various stakeholder perspectives to ensure relevance
and feasibility. We examined perspectives about regis-
tries through a literature review. We subsequently per-
formed neurological patient and caregiver focus groupsl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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The aim of this study was to conduct a “first-look” at the
stakeholder perspectives of patient registries to summarize
our understanding of the literature and to conduct focus
groups in order to assess relevance to neurological pa-
tients in our region.Methods
Literature review
A literature review aiming to identify all patient registry-
related literature was performed using search terms such
as register, registry and registries. The search strategy
(see Additional file 1) was developed in consultation
with an experienced research librarian (D.L.) and in-
cluded the following databases: MEDLINE, EMBASE,
PubMED, the Cochrane Library, PsycINFO, ABI Inform,
BIOSIS Previews, and PAIS. The flow of article identifi-
cation and screening is summarized in Figure 1.
Duplicate citations and non-English articles were re-
moved. Rather than apply strict inclusion and exclusion
criteria to abstracts reviewed we applied two broad
inclusion criteria: 1) the article pertained to patient
registries; and 2) the article reported perceptions about
patient registries from any relevant stakeholder. We
assessed reviewer abstract selection agreement by pilot-
testing these inclusion criteria on a sample of 100
abstracts. We then employed a consecutive reviewer
method whereby one reviewer excluded clearly irrelevant
abstracts followed by a second reviewer who then re-
screened the relevant and possibly relevant abstracts for
inclusion in the secondary review. Relevant articles
underwent full text review. Articles relevant to perspec-
tives regarding patient registries were abstracted for rele-
vant details using Microsoft Excel 2007 (Redmond,
Washington) and a descriptive summary was generated.
Summaries were synthesized qualitatively based upon
relevance to patient registries (Additional file 2).Focus groups
Recruitment and data collection
Focus group participants were recruited through neur-
ology clinics in Calgary, Canada through physician
referrals. A purposive sampling strategy was used, with
the goal of recruiting a variety of people living with
neurological conditions and their caregivers/parents who
would be able to actively participate. Exclusion criteria
included developmental delay, cognitive or language im-
pairment that would preclude active participation in the
focus group discussions. A one-page information sheet
about the research project and the purpose of the focus
groups, along with the synthesized literature review was
provided to the focus group leaders as background for
discussion.Three focus groups were conducted in April 2012 led
by experienced focus group facilitators (G.M., L.C.) and
included: 1) parents of children with neurological condi-
tions; 2) patients with dystonia, epilepsy or multiple
sclerosis and their caregivers; and 3) patients living with
amyotrophic lateral sclerosis (ALS), Huntington’s disease
or Parkinson’s disease and their caregivers. The compos-
ition of the groups was designed to facilitate common
themes and open conversation among the participants
(i.e. common themes between caregivers of adult neuro-
degenerative conditions versus common themes between
caregivers of children with neurological conditions).
Each focus group was 90 minutes in length. Each par-
ticipant received a $10 honorarium to contribute to
travel and parking costs. The questions used to guide
the focus group discussion are outlined in Table 1.
Part-way through the focus group sessions, just before
question 4 in Table 1, each participant was provided a
worksheet outlining the kinds of information that might
be collected by a registry. The focus group participants
were given a few minutes to complete the provided
worksheet, before entering into group discussion about
the kinds of information they were comfortable sharing,
the kinds they would be less comfortable sharing and
why. Participants were asked about other kinds of infor-
mation (i.e., not included on the worksheet) that could
be collected through registries. The unidentified com-
pleted worksheets were collected at the end of the focus
groups with each participant’s consent.Data management and analysis
The focus groups were audio-taped and transcribed,
with back-up notes taken. Using constant comparative
analysis, transcripts and notes were reviewed with the
purpose of identifying key themes relative to the focus
group questions. Constant comparative analysis is inter-
pretational and theory building, and involves moving
back and forth between data collection and analysis [4].
The two analysts (G.M. & L.C.) did preliminary analysis
of the data collected after each focus group, and then
used these preliminary themes to inform the questioning
in subsequent focus groups. More in-depth analysis and
interpretation as the focus groups progressed involved
looking for both similarities and differences, within and
between focus groups, with the goal of identifying key
themes as well as the relationships between them. Data
management and analysis was facilitated through the
use of mind-mapping software, MindJet, San Francisco,
California).Ethics approval
Due to the involvement of patients, families and care-
givers in the focus group portion of the project, ethics
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Figure 1 Registry literature review flowchart.
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Conjoint Health Research Ethics Board and the Public
Health Agency of Canada Ethics Review Board. All focus
group participants provided their informed consent prior
to the commencement of the focus group.Table 1 Focus group questions
1. Round-table introductions, including: Why were you interested
in coming out to this focus group tonight?
2. Generally, what are your thoughts about patient registries?
3. Why might you/your family member be interested in
participating in a registry?
4. What might concern you about participating in a registry?
5. What are your thoughts about this information and how it
is shared (i.e., information included in a worksheet handout)?
6. What words of advice would you give to doctors and other health
professionals about inviting patients to participate in a registry?
Is there anything else you would like to say?Results
Literature review
We identified 19,002 abstracts with 6,435 remaining
after duplicates were removed as summarized in
Figure 1. The first reviewer excluded 2,238 abstracts
with an additional 3,787 subsequently excluded by the
second reviewer. Full text review was performed on
410 articles. A total of 24 articles were included in the
final synthesis. Identified stakeholders from the litera-
ture review included registry participants (i.e. pa-
tients), clinical care providers (treating physicians
often in possession of medical data), research ethics
boards, and data users (researchers, governmental
agencies, health medical organizations).
Participants
In general, most participants have an understanding of
the purpose and nature of registries and are in favour of
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tries included the importance of altruism, use of data for
legitimate purposes by responsible people, advancement
of research that improves the possibility of a treatment
or cure among other factors (see Table 2).
Identified barriers to registry participation included:
(1) concerns about privacy – particularly around the risk
of data falling into the hands of employers especially for
current and former health sector clients; [10] (2) con-
cerns about additional visits particularly physical visits
as well as associated transportation and financial cost
[6,11,12]. Concerns regarding privacy were a strong pre-
dictor of willingness to participate in a registry [13].
However, many participants were unconcerned about
the inclusion of identifiers in the registry, particularly if
it facilitated research contact [14].
With respect to registry services participants have a
strong desire for information including educational out-
reach activities, [15] and up to date discussion of the lat-
est prevention, treatment and disease research, [16]
especially if tailored to individual needs or disease sub-
types, [7] however there is a clear preference for contact
with a known provider over registry personnel [15].
Toll-free assistance services, [15] and other similar ini-
tiatives may thus be a poor use of limited resources.
There was a desire from registry participants to see
regular communication of results (e.g. annual reports,
newsletters) in lay language, [7] however again while it
was preferred that these were interactive, sophisticated
technologies such as videos were not preferred [7]. In
some disease audiences there was a desire for support
and services (e.g. equipment) as well as family support
especially for siblings of affected children [7].
Clinical care providers are motivated to participate in
a registry project if burden is minimal, data entry is effi-
cient and simple, [17] operation is low cost, [18] and re-
sults or outcomes are relevant to clinical practice or
research interests [19,20]. Additionally there is a strong
desire to see registry data be freely exchanged andTable 2 Motivating factors for patient participation
in registries
1. Altruistic attitudes – the perception of benefit to the greater
good even beyond immediate individual benefit or the
potential for individual benefit [10,16]
2. That data will be used by responsible people for legitimate
purposes – participants desire clear purposes for collecting
data and clear methods for its release [10]
3. Advancement in research and the possibility of elucidation of
treatment or cure, [11] and subsequently improved quality of life [16]
4. Desire for prompt information after diagnosis [7]
5. Perception of equal communication with health practitioners and
researchers [7]
6. Other factors influencing participation include satisfaction with care,
[13] age, education, gender and recruiting site [12,22]comparable between departments, regions, and coun-
tries, [5,18] and online registries help to facilitate this
[17]. Finally, provider input at all levels of registry oper-
ation is a key aspect of success [9,19,21]. Where physi-
cians are asked to provide their consent prior to
contacting their patients for a registry there was some
evidence that this interfered with patient recruitment.
In one study, there were noticeable differences in phy-
sicians refusing patient contact between male (1.3%)
and female (4.3%) patients [22].
A significant inhibitor of clinical care provider partici-
pation is mandatory participation due to the perception
that they would be forced to participate in research that
was not relevant to their care or practice or research in-
terests [20]. With respect to registry services, clinical
care providers were generally in favor of activities such
as educational outreach [15]. Overall, early care provider
engagement in registries can provide an opportunity to
develop a collaborative spirit among clinical care pro-
viders and can be utilized as a tool to inform and
standardize clinical practice [19].
Data users
There was limited discussion of researcher or industry
perceptions regarding registries. One study, [23] did as-
sess the perceptions of research teams who had obtained
registry data. All of these researchers reported that the
registry was very (54%) or somewhat useful (46%) [23].
Similarly a clear majority (69%) also found the registry’s
rapid access to health information to be very or some-
what useful. 38% of the research teams reported that
they could have met their recruitment targets using
the registry as the sole recruitment pathway [23]. The
remaining teams reported they would require at least
one other pathway. In general this was clearly delineated
by the specificity of inclusion criteria for the study.
Almost half (46%) of the research teams also reported
that utilizing the registry for recruitment had freed up
personnel resources for non-recruitment activities with
an average savings of 82 hours [23].
Patient recruitment
In several studies the majority of patients were in favor
of being contacted directly about research opportunities
[14,22]. The mechanism of contact between letter or
telephone contact was not reported to have a significant
preference in any literature. Where patients indicated
they desired that their physician be contacted about the
research this was a simple notification rather than a
request for permission [22].
Focus groups
A total of 27 individuals participated in the three focus
groups (see Table 3).
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Participants described a number of reasons why they
might be interested in participating in a registry: to help
others living with neurological conditions; to develop a
“big picture” about a particular condition; to develop
‘best practices’; and to have access to credible, useful
information about their condition.
Altruism emerged as an important factor influencing
people’s willingness to participate in a registry. Most
people were interested in contributing to the generation
of new knowledge that will help people living with these
conditions. This was also reflected in people’s explana-
tions about their interest in participating in these focus
groups.
A number of people liked the idea of having a registry
collecting information about the “big picture” of a
neurological condition(s) (e.g., incidence, prevalence,
natural history of the disease, treatments and outcomes,
co-morbidities). There was discussion about the import-
ance of collecting information about co-morbidities in
one focus group in particular (e.g., the numbers of
people with cerebral palsy who also have epilepsy; the
number of people with MS who also have vascular
problems).
Factors that would influence participation
A number of factors that would influence participation
in a patient registry emerged through the focus groups.
The main factors discussed were that the registry would
need to have:
1. A clear purpose; A number of focus group
participants spoke about the importance of the
registry having a clear purpose, and that the purpose
would need to be clearly articulated to prospectiveTable 3 Focus group participants
Focus group participants Neurological condition
Parent/care-
Group A Epilepsy (4) 9
(n = 9) Hydrocephalus (1)
Muscular dystrophy (1)
Tourette Syndrome (3)
Group B Dystonia (3) 0
(n = 8) Epilepsy (3)
MS (2)
Group C ALS (3) 3
(n = 10) Huntington’s (2)
Parkinson’s (5)
Total 27 12
Group A included only parents of children living with neurological conditions.participants. They would also consent to participate
in a registry if they had a good understanding of
what the registry was being developed for, and why
their participation was important.
2. An opportunity to participate in ethical research
that will ultimately make a difference to people
living with the condition; Some people indicated
that they would want to know if pharmaceutical
company involvement or funding would be
associated with the registry.
Most people stated that they would not want to be dir-
ectly contacted by researchers asking them to participate
in trials, but rather would want the initial invite to come
through their neurologist or neurology clinic. The im-
portant consideration for a number of people was that
the invitation come from someone with whom they had
a trusting relationship, and who knew them and their
condition well. This sentiment was particularly strongly
expressed in Group B. Many of the Group C focus group
participants, however, said they didn’t mind being con-
tacted directly by researchers. This was most strongly
expressed by some of the ALS patients.
3. Appropriate management and sustainability;
Participants discussed wanting assurance that the
registry was well managed and likely to be
sustainable before consenting to participate.
Appropriate participant burden; Some people noted
that the commitment required of them would influence
their interest in participating in a registry. Once again,
the time people would be willing to commit would be
influenced by their view on the value of the registry. A
few people specifically said that they would require anRole Gender
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they would consent to participate in a registry.
Types of information that people are concerned
about sharing
Overall, the majority of people would be happy to share
medical and health information when they understand
how collecting this information helps to advance know-
ledge of a condition, improve treatments, etc. People
expressed far more comfort in sharing their medical in-
formation than their personal information (i.e., informa-
tion that might identify them).
Privacy and security
People did not want to have their personal information
(e.g., name, address, phone number, email, etc.) con-
nected with their medical information. Generally speak-
ing, focus group participants were quite comfortable
with appropriate sharing of anonymised, aggregate med-
ical and health information collected by a registry.
Focus group participants described the onus being on
the registry to keep the information private, with no
ability to connect any personal identifying information
with their medical information. The security provisions
in a patient registry would have to be excellent, and
there would need to be a clear security protocol in
place around the handling, sharing and disposing of
information.
Sharing of information and knowledge
Many participants discussed the importance of ensuring
that the knowledge generated through a registry is dis-
seminated. There was some tension between protecting
privacy while ensuring that access to registry informa-
tion by people with a legitimate need or interest is maxi-
mized. Privacy and confidentiality were felt to be
important, though some people realized that there
needed to be some kind of balance as too much em-
phasis on confidentiality contributes to other problems.
Many [but not all] people want anonymized medical/
health information widely shared if it can assist in the
generation of useful knowledge.
In all focus groups a specific question was asked
about whether people would be concerned with registry
information being transferred to other universities if
any identifying information such as name and address
were removed. None of these focus group participants
expressed concern about the sharing of anonymized
data with other academic centres.
Inviting patients to participate in a registry
The majority of participants indicated that they would
prefer an invitation from their doctor, and preferably
their specialist or someone in the neurology clinic. Insome cases this could be a nurse manager or someone
else affiliated with the clinic. Most people prefer a per-
sonal, individualized approach from someone they know
and trust, and who knows them.
Most focus group participants said they preferred a
personal invitation to participate either over the phone
or face-to-face as this format provides opportunities to
ask questions. Another option described by some would
be to get a personal letter in the mail from someone
you know and trust, which could be followed up with a
meeting and/or phone call.
Recruitment at time of diagnosis
A number of individuals said that it’s generally not a
good idea to approach someone about participating in a
registry when they are newly diagnosed. The timing
post-diagnosis was thought to vary from person to per-
son, with people suggesting that “your medical team
knows when you are ready, knows where you are at.”
Discussion
We performed a comprehensive review of the literature
pertaining to stakeholder perspectives on patient regis-
tries to determine the current state of understanding.
Due to the lack of previous reviews and the large num-
ber of publications pertaining to patient registries this
review was designed as a comprehensive exploratory ra-
ther than standard systematic review method. This
method enabled the inclusion of studies that would have
been excluded if extensive inclusion and exclusion
criteria had been applied. The findings of the literature
review was not limited to neurological registries (Additional
file 3), but rather is based upon the literature relating to
any disease. To investigate the relevance to neurological
conditions focus groups were conducted with patients with
neurological conditions and their caregivers.
Overall, both the literature review and focus groups
support that patients carefully consider registry goals
and operations when deciding whether or not to partici-
pate. Patients expect their information to be managed
appropriately and that the project has a reasonable
chance of resulting in beneficial findings. Patients with
more severe conditions (i.e. ALS) appear to have less re-
luctance about sharing their medical information. This
latter finding may reflect a sense of urgency for research
to develop meaningful treatment options in these more
severely affected patients.
The literature review identified perceptions that
should be important considerations for designing,
implementing and operating patient registries. From a
patient registry participant perspective the literature
supports altruism, responsible use of data and ad-
vancement of research among others as motivating fac-
tors for participating in a patient registry. Barriers to
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ticipant burden (i.e. extra clinic visits and associated
costs). Importantly, a desire to see regular communica-
tion of results was cited. Motivating factors for clinical
care providers included minimal burden, efficient and
simple data entry, low operation cost and relevance of
results or outcomes to their practice or research. Re-
searchers and other data users reported patient regis-
tries to be a generally useful source of data and as a
method of patient recruitment for clinical studies.
Consideration of these motivating factors and barriers
should be given to maximize patient registry interac-
tions with these groups. Registry participants reported
a desire for their care provider to be notified upon
enrollment, a process that can be readily incorporated
into registries.
We subsequently conducted focus groups including
patients and caregivers across the spectrum of neuro-
logical conditions to obtain their perspectives about
registries and specific data that may be collected. These
focus groups re-iterated some of the themes identified
in the literature review. The focus group participants
agreed that in order for them to participate a registry re-
quires a clear purpose. Patients do view participation as
an opportunity to access ethical research that will make
a difference to people. Participant burden is a factor that
in part determines willingness to participate. Patients
feel that they should be able to withdraw from the regis-
try at any time. While patients expressed more concerns
about sharing personal data than medical data, the rele-
vance of the data to the overall aim of the registry was a
strong factor in determining whether their data should
be provided or not. Some differences in the extent to
which focus group participants would consider sharing
data were observed with caregivers of affected children
being more reluctant and patients with ALS being less
reluctant to share data. Overall, findings from focus
groups with patients with neurological conditions and
their caregivers suggest that motivations for this group
are similar to those found in a literature review of pa-
tient registries in general.
The findings are useful for the development of best prac-
tices. Best practices must consider enabling factors and bar-
riers to registry development and operations. Consideration
of stakeholder perspectives is essential to success. As an ex-
ample, our focus groups indicate that patients with neuro-
logical conditions and their caregivers may not be willing
to provide social insurance numbers (SIN). Developing a
registry with administrative data linkage based on SIN may
not be feasible in our region based on these results.
Strict limitations need to be considered when applying
the findings of this study. The literature review did not
employ a “systematic” review methodology increasing
the possibility that a single reviewer did not include arelevant article. We expect that this is unlikely given the
inclusive design of the search strategy and liberal inclu-
sion of articles into the full text review stage. However,
this review did not include non-English articles or sur-
vey the grey literature. Limitations for the focus group
method include the small number of participants from
each disease group. However, the purpose of the focus
groups was to obtain commonalities in the perspectives
of patient registries across the spectrum of adult and
pediatric neurological conditions and the participants in
the focus groups were representative of that aim. Patient
perspectives are likely to vary with geographic, cultural
and socioeconomic differences.
Conclusions
With increasing recognition that patient registries repre-
sent a valid, effective and important methodology for the
collection of prospective observational data and the
continued emergence of new patient registries for neuro-
logical conditions, it is essential to consider the perspec-
tives of all relevant stakeholders. Strategies to motivate
participants, caregivers, stakeholders, governmental and
administrative bodies as well as the research community
are instrumental to successful registry outcomes. This
study examined patient and caregiver perspectives across
the available literature and compared them to those identi-
fied in our local focus groups finding them to be highly
consistent. Future studies should examine consistency of
these findings in other regions with differing cultural norms
and health care systems.
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